The poison pill argument makes some sense to me. However, if the board decides to raise capital at this point in time, it means the board is aligned with the CEO and management team. In this case, the board can easily reject the offer, and there is no need to destruct shareholder value by issuing new capital at low prices.
Ann: Media regarding approach from SQN Investors, page-45
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BTH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.005(2.70%) |
Mkt cap ! $147.9M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 18.0¢ | $139.5K | 760.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 308641 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 78712 | 6 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| BTH (ASX) Chart |